node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
SLC22A15 | SLC22A18 | ENSSSCP00000041665 | ENSSSCP00000059724 | Solute carrier family 22 member 15. | Solute carrier family 22 member 18. | 0.482 |
SLC22A16 | SLC22A18 | ENSSSCP00000004747 | ENSSSCP00000059724 | Solute carrier family 22 member 16. | Solute carrier family 22 member 18. | 0.530 |
SLC22A18 | SLC22A15 | ENSSSCP00000059724 | ENSSSCP00000041665 | Solute carrier family 22 member 18. | Solute carrier family 22 member 15. | 0.482 |
SLC22A18 | SLC22A16 | ENSSSCP00000059724 | ENSSSCP00000004747 | Solute carrier family 22 member 18. | Solute carrier family 22 member 16. | 0.530 |
SLC22A18 | SLC22A2 | ENSSSCP00000059724 | ENSSSCP00000004366 | Solute carrier family 22 member 18. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.505 |
SLC22A18 | SLC22A3 | ENSSSCP00000059724 | ENSSSCP00000004365 | Solute carrier family 22 member 18. | Solute carrier family 22 member 3. | 0.686 |
SLC22A18 | SLC22A4 | ENSSSCP00000059724 | ENSSSCP00000041250 | Solute carrier family 22 member 18. | Solute carrier family 22 member 4. | 0.531 |
SLC22A2 | SLC22A18 | ENSSSCP00000004366 | ENSSSCP00000059724 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 18. | 0.505 |
SLC22A2 | SLC22A3 | ENSSSCP00000004366 | ENSSSCP00000004365 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 3. | 0.911 |
SLC22A2 | SLC22A4 | ENSSSCP00000004366 | ENSSSCP00000041250 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 4. | 0.931 |
SLC22A3 | SLC22A18 | ENSSSCP00000004365 | ENSSSCP00000059724 | Solute carrier family 22 member 3. | Solute carrier family 22 member 18. | 0.686 |
SLC22A3 | SLC22A2 | ENSSSCP00000004365 | ENSSSCP00000004366 | Solute carrier family 22 member 3. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.911 |
SLC22A3 | SLC22A4 | ENSSSCP00000004365 | ENSSSCP00000041250 | Solute carrier family 22 member 3. | Solute carrier family 22 member 4. | 0.924 |
SLC22A4 | SLC22A18 | ENSSSCP00000041250 | ENSSSCP00000059724 | Solute carrier family 22 member 4. | Solute carrier family 22 member 18. | 0.531 |
SLC22A4 | SLC22A2 | ENSSSCP00000041250 | ENSSSCP00000004366 | Solute carrier family 22 member 4. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.931 |
SLC22A4 | SLC22A3 | ENSSSCP00000041250 | ENSSSCP00000004365 | Solute carrier family 22 member 4. | Solute carrier family 22 member 3. | 0.924 |